We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

34 hedge funds and large institutions have $17.6M invested in Greenwich LifeSciences in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

37% more capital invested

Capital invested by funds: $12.9M → $17.6M (+$4.77M)

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

10% more funds holding

Funds holding: 31 → 34 (+3)

2.91% more ownership

Funds ownership: 5.02% → 7.93% (+2.9%)

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
4
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.69M
2
Credit Agricole
Credit Agricole
France
+$1.27M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.01M
4
State Street
State Street
Massachusetts
+$809K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$658K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.27M
2
Goldman Sachs
Goldman Sachs
New York
-$828K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$715K
4
Jane Street
Jane Street
New York
-$412K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$345K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMT
26
Founders Capital Management (Texas)
Texas
$8.63K – – –
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$7.47K +$6.33K +433 New
AB
28
Amalgamated Bank
New York
$4K +$3.02K +207 New
WTA
29
Washington Trust Advisors
Massachusetts
$3.45K – – –
Fidelity Investments
30
Fidelity Investments
Massachusetts
$1.55K – – –
GWM
31
Geneos Wealth Management
Colorado
$1.52K – – –
Northwestern Mutual Wealth Management
32
Northwestern Mutual Wealth Management
Wisconsin
$1.04K +$876 +60 New
NSIM
33
North Star Investment Management
Illinois
$880 – – –
Millennium Management
34
Millennium Management
New York
– -$1.27M -63,811 Closed
Goldman Sachs
35
Goldman Sachs
New York
– -$828K -41,505 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$715K -35,870 Closed
Jane Street
37
Jane Street
New York
– -$412K -20,642 Closed
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
– -$345K -17,317 Closed
HF
39
HRT Financial
New York
– -$302K -15,165 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$10.6K -530 Closed
GPFA
41
Game Plan Financial Advisors
Ohio
– -$3.99K -200 Closed
Macquarie Group
42
Macquarie Group
Australia
– -$2 -110 Closed
OPTFSNA
43
Old Point Trust & Financial Services N A
Virginia
– -$1.99K -100 Closed
CAL
44
Capital Advisors Ltd
Ohio
– -$15 -1 -33%
1
2

GLSI Hedge Fund Activity: Q2 2024 in Review

34 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2024, worth a combined $17.6M — up 37% from $12.9M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GLSI positions and 10 closed out — a net gain of 3 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $3.69M. The largest seller was Millennium Management, exiting entirely with an estimated $1.27M sold.

  • 34 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2024, up from 31 in Q1 2024.
  • Funds reported $17.6M of Greenwich LifeSciences stock for Q2 2024, up 37% quarter-over-quarter.
  • 13 funds opened new Greenwich LifeSciences positions in Q2 2024 and 10 closed out, a net change of +3 holders.
  • The largest Greenwich LifeSciences buyer in Q2 2024 was BlackRock, an estimated $3.69M added.
  • The largest Greenwich LifeSciences seller in Q2 2024 was Millennium Management, an estimated $1.27M sold.

Based on aggregated 13F filings for Q2 2024.